drugset / Trial / NCT04608682

Effect of Muscle Relaxation Reversal on the Success Rate of Motor Evoked Potential Recording

NCT04608682 ↗

Completed 170 enrolled Beijing Tiantan Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

Transcranial motor evoked potential (TcMEP) monitoring is conventionally performed during surgery without or with minimal neuromuscular blockade (NMB) because of its potential interference with signal interpretation.The feasibility of TcMEP interpretation was assessed during partial NMB in adult neurosurgical patients. However, partial NMB may interfere record of TcMEP monitoring. Sugammadex is the first highly selective antagonist that can reverse NMB. This study aims to evaluate the success rate of intraoperative muscle relax reversal by sugammadex on intraoperative TceMEP recording.

Timeline

Start
2021-08-16
Primary completion
2022-08-30
Completion
2022-08-30

Outcome

Met primary endpoint

paper The success rate of TceMEP monitoring in the sugammadex group was significantly higher than that in the control group. PMID 37626303 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Sugammadex Other / unclassified 2 mg/kg —

Indications

No indication recorded.